(2,3,4,5-tetrahydro-4-oxo-1,5-benzothiazepin-3-yl)carbamic acid,1,1-dimethylethyl ester | 92976-42-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并硫氮卓类
• 英文名称: (2,3,4,5-tetrahydro-4-oxo-1,5-benzothiazepin-3-yl)carbamic acid,1,1-dimethylethyl ester
• 英文别名: 3-t-butyloxycarbonylamino-2,3-dihydro-1,5-benzthiazepin-4(5H)-one；(S)-tert-butyl (4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl)carbamate；tert-butyl N-(4-oxo-3,5-dihydro-2H-1,5-benzothiazepin-3-yl)carbamate
• CAS: 92976-42-6
• 化学式: C₁₄H₁₈N₂O₃S
• 分子量: 294.375
• InChiKey: YHSONFJMJNCOAE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  92.7
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (2,3,4,5-tetrahydro-4-oxo-1,5-benzothiazepin-3-yl)carbamic acid,1,1-dimethylethyl ester 生成 3-amino-3,4-dihydro-4-oxo-1,5-benzothiazepine-5(2H)-acetic acid,ethyl ester
  参考文献：
  名称：

  KARANEWSKY, DONALD S.

  摘要：

  DOI：
• 作为产物：
  描述：

  (R)-S-(2-aminophenyl)-N-(tert-butyloxycarbonyl)cysteine 以 5,5-dimethyl-1,3-cyclohexadiene 为溶剂， 生成 (2,3,4,5-tetrahydro-4-oxo-1,5-benzothiazepin-3-yl)carbamic acid,1,1-dimethylethyl ester
  参考文献：
  名称：

  Acylamino oxo or hydroxy substituted alkylamino thiazines and thiazepines

  摘要：

  公式##STR1##的化合物以及X是氧化取代的噻嗪或噻唑啉的化合物被披露。这些化合物具有血管紧张素转换酶抑制活性，因此可作为降压药使用。

  公开号：

  US04512988A1

文献信息

• Acylamino oxo or hydroxy substituted alkylamino thiazines and thiazepines
  申请人：E. R. Squibb & Sons, Inc.

  公开号：US04512988A1

  公开（公告）日：1985-04-23

  Compounds of the formula ##STR1## and X is an oxo substituted thiazine or thiazepine are disclosed. These compounds possess angiotensin converting enzyme inhibition activity and are thus useful as hypotensive agents.

  公式##STR1##的化合物以及X是氧化取代的噻嗪或噻唑啉的化合物被披露。这些化合物具有血管紧张素转换酶抑制活性，因此可作为降压药使用。
• Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
  申请人：——

  公开号：US20040142938A1

  公开（公告）日：2004-07-22

  Prodrugs of a glycogen phosphorylase inhibiting compounds are provided, said prodrug compounds having the formula I G(—O 2 CR′) m (—OH) n (—O 2 C(CH 2 ) p CH 3 ) q I wherein G is a C 3 to C 5 branched or straight carbon chain and (—O 2 CR′), (—OH) and (—O 2 C(CH 2 ) p CH 3 ) are attached to any available carbon atom along G; m is an integer from 1 to 4; n is an integer from 0 to 3; p is an integer from 0 to 16; q an integer from 0 to 3; where the sum of m, n and q is 3 or 4; and —O 2 CR′ is a fragment of a compound of formula 1 wherein W, X, Y, Z, R 1 and R 2 are as defined herein. Further provided are pharmaceutical compositions and methods for treating diabetes and related diseases employing compounds above, either alone or in combination with another therapeutic agent.

  提供了一种糖原磷酸化酶抑制化合物的前药，所述前药化合物具有以下式I G(—O 2 CR′) m (—OH) n (—O 2 C(CH 2 ) p CH 3 ) q I 其中G是C 3 到C 5 支链或直链碳链，(—O 2 CR′)、(—OH)和(—O 2 C(CH 2 ) p CH 3 )连接到G上的任何可用碳原子上； m是从1到4的整数； n是从0到3的整数； p是从0到16的整数； q是从0到3的整数；其中m、n和q的总和为3或4；以及 —O 2 CR′是具有以下式的化合物的片段 1 其中W、X、Y、Z、R 1 和R 2 如本文所定义。 还提供了使用上述化合物治疗糖尿病和相关疾病的药物组合物和方法，可以单独使用或与另一种治疗剂联合使用。
• Lactam glycogen phosphorylase inhibitors and method of use
  申请人：——

  公开号：US20040002495A1

  公开（公告）日：2004-01-01

  A compound of formula I 1 wherein W is a bicyclic hetroaryl of the structure 2 X is —O—, —S—, —SO 2 —, —CHR 5 —, —CHR 5 O—, —CHR 5 S—, —CHR 5 SO 2 —, —CHR 5 CO— or —CH 2 CHR 5 —; Y is a bond or —CHR 6 —; Z is an aryl or heteroaryl group of the following structure: 3 A is —CH— or —N—; B is —O— or —S—; and R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are as described herein. Further provided is a method for treating diabetes and related diseases employing a glycogen phosphorylase inhibiting amount of the above compound, either alone or in combination with another therapeutic agent.

  公式I的化合物 其中 W是具有结构的双环杂芳基 X是—O—，—S—，—SO 2 —，—CHR 5 —，—CHR 5 O—，—CHR 5 S—，—CHR 5 SO 2 —，—CHR 5 CO—或—CH 2 CHR 5 —; Y是一个键或—CHR 6 —; Z是以下结构的芳基或杂芳基团： A是—CH—或—N—; B是—O—或—S—; 和 R 1 ，R 2 ，R 3 ，R 4 ，R 5 ，R 6 ，R 7 和R 8 如本文所述。 此外，提供了一种治疗糖尿病和相关疾病的方法，该方法使用上述化合物的糖原磷酸化酶抑制剂量，可以单独使用或与另一种治疗剂联合使用。
• 2-ALKOXY-3,4,5-TRIHYDROXY-ALKYLAMIDES, PREPARATION THEREOF, COMPOSITIONS CONTAINING THEM AND USE THEREOF
  申请人：ZHANG Jidong

  公开号：US20070244087A1

  公开（公告）日：2007-10-18

  The invention relates particularly to 2-alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof as a medicament, particularly as anti-cancer agents.

  该发明特别涉及2-烷氧基-3,4,5-三羟基-烷酰胺，其制备方法，含有它们的组合物以及将其用作药物，特别是作为抗癌剂的用途。
• Substituted Benzodiazepinones, Benzoxazepinones and Benzothiazepinones as Sodium Channel Blockers
  申请人：Hoyt Scott B.

  公开号：US20100144715A1

  公开（公告）日：2010-06-10

  The present invention is directed to substituted benzodiazepinones, benzoxazepinones and benzothiazepinones compounds that are sodium channel blockers useful for the treatment of chronic and neuropathic pain. The compounds of the present invention are also useful for the treatment of other conditions, including disorders of the CNS such as anxiety, depression, epilepsy, manic depression and bipolar disorder. This invention also provides pharmaceutical compositions comprising a compound of the present invention, either alone, or in combination with one or more therapeutically active compounds, and a pharmaceutically acceptable carrier. This invention further comprises methods for the treatment of acute pain, chronic pain, visceral pain, inflammatory pain, neuropathic pain and disorders of the CNS including, but not limited to, epilepsy, manic depression, depression, anxiety and bipolar disorder comprising administering the compounds and pharmaceutical compositions of the present invention.

  本发明涉及替代苯二氮平酮、苯并噁唑酮和苯并噻唑酮化合物，它们是钠通道阻滞剂，可用于治疗慢性和神经病理性疼痛。本发明的化合物也可用于治疗其他疾病，包括中枢神经系统紊乱，如焦虑、抑郁、癫痫、躁郁症和双相障碍。本发明还提供了含有本发明化合物的药物组合物，可以单独使用或与一个或多个治疗活性化合物组合使用，并与药学上可接受的载体一起使用。本发明还包括治疗急性疼痛、慢性疼痛、内脏疼痛、炎症性疼痛、神经病理性疼痛和中枢神经系统紊乱的方法，包括但不限于癫痫、躁郁症、抑郁症、焦虑症和双相障碍，通过给予本发明的化合物和药物组合物进行治疗。